Cobas EGFR Mutation Test v2 regulatory update

FDA approved a PMA from Roche for a blood-based version of its cobas EGFR Mutation Test v2 as a companion diagnostic for Tagrisso osimertinib from AstraZeneca to treat EGFR T790M mutation-positive, m...